Viewing StudyNCT00006019



Ignite Creation Date: 2024-05-05 @ 11:07 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006019
Status: COMPLETED
Last Update Posted: 2013-06-24
First Post: 2000-07-05

Brief Title: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia Myelodysplasia Non-Hodgkins Lymphoma Multiple Myeloma Non-small Cell Lung Cancer or Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Prostate Cancer
Keywords:
Name View
recurrent non-small cell lung cancer View
refractory multiple myeloma View
recurrent adult acute myeloid leukemia View
recurrent prostate cancer View
adult acute myeloblastic leukemia without maturation M1 View
adult acute myeloblastic leukemia with maturation M2 View
adult acute promyelocytic leukemia M3 View
adult acute myelomonocytic leukemia M4 View
adult acute monoblastic leukemia M5a View
recurrent grade 1 follicular lymphoma View
recurrent grade 2 follicular lymphoma View
recurrent grade 3 follicular lymphoma View
recurrent adult diffuse small cleaved cell lymphoma View
recurrent adult diffuse mixed cell lymphoma View
recurrent adult diffuse large cell lymphoma View
adult acute monocytic leukemia M5b View
previously treated myelodysplastic syndromes View
secondary myelodysplastic syndromes View
recurrent marginal zone lymphoma View
recurrent small lymphocytic lymphoma View
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
nodal marginal zone B-cell lymphoma View
splenic marginal zone lymphoma View